Figures
Abstract
Objectives
The aim of this study was to utilise corneal confocal microscopy to quantify corneal nerve morphology and establish the presence of sub-clinical small fibre damage and peripheral neuropathy in children with celiac disease.
Methods
This is a cross-sectional cohort study of twenty children with celiac disease and 20 healthy controls who underwent clinical and laboratory assessments and corneal confocal microscopy. Corneal nerve fiber density (no.mm2), corneal nerve branch density (no.mm2), corneal nerve fiber length (mm.mm2), corneal nerve fiber tortuosity and inferior whorl length (mm.mm2) were quantified manually.
Results
Corneal nerve fiber density (34.7±8.6 vs. 32.9±8.6; P = 0.5), corneal nerve branch density (47.2±24.5 vs. 47.3±20.0; P = 0.1) and corneal nerve fiber length (20.0±5.1 vs. 19.5±4.5; P = 0.8) did not differ between children with celiac disease and healthy controls. Corneal nerve fiber tortuosity (11.4±1.9 vs 13.5±3.0; P = 0.01) was significantly lower and inferior whorl length (20.0±5.5 vs 23.0±3.8; P = 0.06) showed a non-significant reduction in children with celiac disease compared to healthy controls. Inferior whorl length correlated significantly with corneal nerve fiber density (P = 0.005), corneal nerve branch density (P = 0.04), and corneal nerve fiber length (P = 0.002).
Citation: Gad H, Saraswathi S, Al-Jarrah B, Petropoulos IN, Ponirakis G, Khan A, et al. (2020) Corneal confocal microscopy demonstrates minimal evidence of distal neuropathy in children with celiac disease. PLoS ONE 15(9): e0238859. https://doi.org/10.1371/journal.pone.0238859
Editor: James Wolffsohn, Aston University School of Life and Health Sciences, UNITED KINGDOM
Received: June 2, 2020; Accepted: August 25, 2020; Published: September 21, 2020
Copyright: © 2020 Gad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: This publication was made possible by a Sidra Internal Research Fund (SIRF) and a Biomedical Research Program [BMRP- 5726113101] grant from the Qatar National Research Fund (QNRF). The statements made herein are solely the responsibility of the authors.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Celiac disease (CD) occurs in approximately 0.2–5.5% of children [1]. CD is classically associated with gastrointestinal (GI) symptoms such as diarrhea, abdominal pain, malabsorption and weight loss. However, there are an increasing proportion of patients with CD who present with extraintestinal manifestations involving the musculoskeletal, cardiovascular and neurological systems and present with short stature, anemia, osteoporosis and arthritis [2].
Neurological manifestations including cerebellar ataxia, gluten encephalopathy, sensorineural hearing loss, headache and cognitive decline occur in about 10% of adults with CD [3]. A recent systematic review established that up to 39% of adults with CD may have gluten neuropathy [4]. Luostarinen et al demonstrated a chronic axonal neuropathy using quantitative needle electromyography (EMG) in 23% of patients with CD [5]. Peripheral neuropathy may develop independent of enteropathic symptoms or lack of adherence to a gluten free diet (GFD) [6]. Chin et al, found a small fiber neuropathy characterized by burning, tingling and numbness in the hands and feet and diffuse paraesthesiae involving the face, trunk, and lumbosacral region in 40% of adults with CD, mildly abnormal electrophysiology in 90% and a mild-to-severe axonopathy in nerve biopsies [7]. In a study of 13 CD patients, 8 had neuropathic pain, 6 had cerebellar ataxia, 1 had white matter abnormalities on magnetic resonance imaging (MRI) of the brain and 1 had ataxia and cortical myoclonus [8]. A nationwide population-based study of patients with biopsy verified-CD reported an absolute risk of neuropathy of 64 per 100,000 person years in CD patients compared to 15 per 100,000 in matched controls; with an estimated risk of neuropathy being highest in the early years of diagnosis with CD (HR 4.4; 95% CI 2.6–7.4; P < 0.001) [9].
There are limited data showing evidence of peripheral neuropathy in children with CD. In a study of 27 children with CD, 3 (11%) had sub-clinical neuropathy with axonal neuropathy on electromyography in 2 (7%) and prolonged somatosensory evoked potentials in 1 patient [10]. Neurophysiological studies are highly sensitive, but are not easily performed in children [11]. Quantitative sensory testing to evaluate vibration and thermal perception thresholds are easy to perform, but lack reproducibility, especially in children and skin or nerve biopsies are invasive procedures [12]. Corneal confocal microscopy (CCM) is a rapid, non-invasive and well-tolerated ophthalmic imaging technique that has been used to objectively quantify neurodegeneration in adults with metabolic [13–20], cerebrovascular [21–24] and central neurodegenerative [25–28] diseases. We have also shown a significant reduction in corneal nerve fibre density, branch density and length in children and adolescents with type 1 diabetes mellitus (T1DM) [29,30] and progression over time [31]. CCM is a well-tolerated technique for the early detection of neuropathy in children with T1DM [32]. The aim of this study was to utilise CCM to quantify corneal nerve morphology in the central cornea and inferior whorl to establish the presence of sub-clinical small fibre damage and peripheral neuropathy in children with CD.
Methods
Twenty participants with CD and 20 age-matched healthy controls underwent CCM in the outpatient department of Sidra Medicine between January 2019 to October 2019. Patients with a history of any other cause of neuropathy, malignancy, deficiency of B12 or folate, chronic renal, liver failure, connective tissue or systemic disease, previous corneal trauma or systemic disease affecting the cornea, ocular surgery, LASIK and a history of or current contact lens wear were excluded from the study. Both eyes were examined, and it took around 10 minutes to capture central and peripheral corneal nerve images. Clinical and metabolic data were collected from the nearest clinic visit and healthy participants did not undergo any clinical tests. All participants provided written assent and parental informed consent and the research adhered to the tenets of Declaration of Helsinki and was approved by Sidra Medicine (IRB 1500758–3) and Weill Cornell Medicine (IRB 17–00032) Research Ethics Committee.
Corneal confocal microscopy procedure
Using the Heidelberg Retina Tomograph Cornea Module (Heidelberg Engineering, Germany), all participants underwent CCM. Two eyes were anaesthetized with 2 drops of Bausch & Lomb Minims® (Oybuprocaine hydrochloride 0.4% w/v). Oybuprocaine hydrochloride drops are used to numb the eyes to limit irritation or discomfort during the procedure. A drop of hypotears gel (Carbomer 0.2% eye gel) was placed on the tip of the objective lens and a sterile disposable TomoCap was placed over the lens, allowing optical coupling of the objective lens to the cornea to focus on the sub basal nerve plexus (SBNP). Images were taken by a single investigator (HG) to capture several layers of the cornea; epithelium, SBNP, stroma, endothelium, and inferior whorl.
Image selection and quantification
Six images overlapping by no more than 20% were selected from the central cornea based on the quality of images, absence of artifacts such as pressure lines and other layers as well as out of focus images. Corneal nerve fiber density (CNFD) (fibres/mm2) corneal nerve branch density (CNBD) (branches/mm2) and corneal nerve fiber length (CNFL) (mm/mm2) were quantified manually and corneal nerve fiber tortuosity (CNFT) was quantified automatically from the trace of the main corneal nerve fibres using CCMetrics (Fig 1A and 1B). An additional six images centred on the inferior whorl and immediately adjacent areas not overlapping by no more than 20% were selected and the inferior whorl length (IWL) (mm/mm2) was quantified utilizing the manual CNFL mode in CCMetrics [33] (Fig 1C and 1D). The investigator was blind to the study group when performing CCM and analysing CCM images.
Sample size and statistical analysis
The primary outcome measure was corneal nerve fiber pathology as assessed with CCM. A difference in nerve fiber length of 2.7 mm/mm2 has been demonstrated to be a clinically significant difference representing the difference between mean nerve fiber length in controls and individuals with mild diabetic neuropathy [34]. The standard deviation for nerve fiber length (mm/mm2) in controls has been reported to be 0.88 [35]. Using these parameters, a power of 0.80 and a two-tailed alpha of 0.05, a minimum sample size of 16 was calculated per group. Given the lack of precision associated with this calculation we increased the sample size to 20 per group to improve the power of the study.
All statistical analyses were performed using IBM SPSS Statistics software Version 26 and P<0.05 was considered statistically significant. Normally distributed data were expressed as mean ± standard deviation and the means were compared using an independent sample t-test. To investigate the association between clinical parameters and corneal nerve fibres parameters, Pearson correlation was used. Graph prism version 8 was used to build dot plots.
Results
Clinical demographics are summarized in Table 1. The body mass index (BMI) (18.82±3.90 vs. 22.26±5.47; P = 0.031) and 25 OHD (25-hydroxyvitamin D) (43.50±13.36 vs. 59.77±22.45; P = 0.014) levels were significantly lower in children with CD compared to controls. There was no difference in CNFD (34.7±8.6 vs. 32.9±8.6; P = 0.5), CNBD (47.2±24.5 vs. 47.3±20.0; P = 0.1) and CNFL (20.0±5.1 vs. 19.5±4.5; P = 0.8) (Fig 2A–2C). CNFT (11.4±1.9 vs 13.5±3.0; P = 0.01) was significantly lower in children with CD compared to controls (Fig 2D). IWL demonstrated a non-significant reduction in patients with CD compared to healthy controls (20.0±5.5 vs 23.0±3.8; P = 0.1) (Fig 2E). IWL was >2SD lower than the mean of controls in 20% of children with CD.
(A) CNFD: Corneal nerve fiber density, (B) CNBD: corneal nerve branch density, (C) CNFL: corneal nerve fiber length, (D) CNFT: corneal nerve fiber tortuosity, (E) IWL: Inferior whorl length.
Correlation between CCM parameters and clinical and laboratory measures
Age, duration of disease, height, BMI, tissue transglutaminase antibody level, haemoglobin, 25 OHD, vitamin B12, folic acid and iron levels did not correlate with CNFD, CNBD, CNFL, CNFT or IWL. Platelet count showed a significant inverse correlation with CNBD (B = -0.539; P = 0.017) and CNFL (B = -0.544; P = 0.016) (Fig 3A and 3B).
CNBD: corneal nerve branch density, CNFL: corneal nerve fiber length.
Correlation between central corneal and inferior whorl corneal nerve parameters
IWL correlated significantly with CNFD (B = 0.606; P = 0.005), CNBD (B = 0.459; P = 0.042) and CNFL (B = 0650; P = 0.002) but not with CNFT (B = -0.227, P = 0.337) (Fig 4A–4D).
IWL: Inferior whorl length, CNFD: Corneal nerve fiber density, CNBD: corneal nerve branch density, CNFL: corneal nerve fiber length, CNFT: corneal nerve fiber tortuosity.
Discussion
This is the first study to assess corneal nerve morphology in children with celiac disease. We demonstrate no loss of corneal nerve fibres in the central cornea and a non-significant reduction in the inferior whorl length in children with CD. We believe it is critical to detect early sub-clinical nerve damage using sensitive techniques such as CCM to ensure compliance with a gluten-free-diet to prevent progressive nerve degeneration. However, our data indicate that children with CD do not have evidence of subclinical small nerve fibre damage. This is contrast to a nationwide population-based study of adults with biopsy verified-CD, where the prevalence of confirmed neuropathy was increased based on the International Classification of Disease (ICD) codes for any neuropathy, idiopathic neuropathy, Guillain-Barre Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), mononeuritis multiplex and autonomic neuropathy [9]. Indeed, adults with CD have reported symptoms of burning, tingling, and numbness in the hands and feet which has been attributed to an underlying small fibre neuropathy [7]. Furthermore, abnormalities in electrophysiology and nerve biopsy [5,7], reduced nerve conduction studies (NCS) [5,8] and abnormal QST [8] have been shown in adults with CD. Skin biopsy studies in adults with CD have also demonstrated periodic acid Schiff-positive and diastase resistance intracellular bodies in apocrine sweat glands [36], reduced intraepidermal nerve fiber density [37–39], increased axonal swelling and collateral reinnervation [40,41] in the calf and thigh [39]. Furthermore, sural nerve biopsy studies have shown a mild to moderately severe chronic axonopathy [7,42,43], focal inflammatory cell infiltrates in the epineurium and perivascular cuffing of the lymphocytes [42,43] with a patchy loss of myelinated fibers [42].
Peripheral neuropathy is associated with T1DM and CD; however, it is unclear whether T1DM patients with CD have an increased risk of neuropathy compared to either disease alone [44]. There is only one previous study which showed electromyographic evidence of axonal neuropathy in 7% of children with CD [10]. A case-report of a sural nerve biopsy from a child with CD demonstrated reduced unmyelinated fiber density, indicative of an early small fiber neuropathy [45]. The present study shows no reduction in central corneal nerve fibres in children with CD compared to healthy controls using CCM. This indicates that children with CD do not show a reduction in corneal nerves comparable to children with T1DM [11,31,46]. Although gluten neuropathy is common in adults with CD [4], in children with CD we show no evidence of corneal nerve loss. In a recent systematic review, age was the main driver of neuropathy in patients with CD [4]. Furthermore, we have observed a significant lower corneal nerve fibre tortuosity. This is in contrast with the observation that corneal nerve fibre tortuosity was increased in patients with diabetes [47,48]. This further supports a lack of evidence for small fibre degeneration in children with CD. However, the inferior whorl which is more distal to the central corneal nerves has shown an early loss in adults with diabetes [33,49–51], particularly in those with painful diabetic neuropathy [52,53]. We show a trend towards a reduction in IWL in children with CD compared to healthy controls and may be clinically relevant as it may help to identify children with very early nerve damage, particularly as 20% had a reduction which was >2SD of the mean in controls. The correlation between IWL and central corneal nerve measures is in agreement with a previous study in adults [49] and further supports a common underlying basis for corneal nerve loss at the centre and inferior whorl.
There were no associations between CCM measures and clinical variables such as BMI and vitamin D even though these were lower in CD and there was no association with tissue transglutaminase antibody levels or duration of disease. Whilst there was no difference in platelet density between children with CD and controls, paradoxically there was a significant inverse correlation with corneal nerve fibre measures. Previous studies have not shown a relationship between platelet density and corneal nerves or neuropathy. Platelets are rich in platelet derived growth factor which promotes the chemotaxis of fibroblasts, monocytes and macrophages and also inhibits metalloprotease activity and decreases inflammation [54]. Indeed, platelet lysate has been shown to improve corneal nerve fibre density and symptoms in patients with dry eye [55].
A limitation of the current study is the cross-sectional design and the small cohort size which may have resulted in the study being underpowered. Larger longitudinal studies are warranted, given the trend for a reduction in IWL suggesting very early distal nerve fibre loss in CD.
Conclusion
We conclude that there is minimal evidence of small nerve fibre damage in children with CD.
References
- 1. Kakleas K, Soldatou A, Karachaliou F, Karavanaki K. Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Autoimmun Rev. 2015;14(9):781–97. Epub 2015/05/24. pmid:26001590.
- 2. Husby S, Murray JA. Diagnosing coeliac disease and the potential for serological markers. Nat Rev Gastroenterol Hepatol. 2014;11(11):655–63. Epub 2014/10/01. pmid:25266110.
- 3. Casella G, Bordo BM, Schalling R, Villanacci V, Salemme M, Di Bella C, et al. Neurological disorders and celiac disease. Minerva gastroenterologica e dietologica. 2016;62(2):197–206. Epub 2015/12/02. pmid:26619901.
- 4. Mearns ES, Taylor A, Thomas Craig KJ, Puglielli S, Leffler DA, Sanders DS, et al. Neurological Manifestations of Neuropathy and Ataxia in Celiac Disease: A Systematic Review. Nutrients. 2019;11(2). Epub 2019/02/15. pmid:30759885.
- 5. Luostarinen L, Himanen SL, Luostarinen M, Collin P, Pirttila T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. Journal of neurology, neurosurgery, and psychiatry. 2003;74(4):490–4. Epub 2003/03/18. pmid:12640070.
- 6. Chin RL, Latov N, Green PH, Brannagan TH 3rd, Alaedini A, Sander HW. Neurologic complications of celiac disease. Journal of clinical neuromuscular disease. 2004;5(3):129–37. Epub 2004/03/01. pmid:19078733.
- 7. Chin RL, Sander HW, Brannagan TH, Green PH, Hays AP, Alaedini A, et al. Celiac neuropathy. Neurology. 2003;60(10):1581–5. Epub 2003/05/29. pmid:12771245.
- 8. Zis P, Sarrigiannis PG, Rao DG, Sanders DS, Hadjivassiliou M. Small fiber neuropathy in coeliac disease and gluten sensitivity. Postgraduate medicine. 2019:1–5. Epub 2019/07/31. pmid:31359810.
- 9. Thawani SP, Brannagan TH 3rd, Lebwohl B, Green PH, Ludvigsson JF. Risk of Neuropathy Among 28,232 Patients With Biopsy-Verified Celiac Disease. JAMA neurology. 2015;72(7):806–11. Epub 2015/05/12. pmid:25962148.
- 10. Cakir D, Tosun A, Polat M, Celebisoy N, Gokben S, Aydogdu S, et al. Subclinical neurological abnormalities in children with celiac disease receiving a gluten-free diet. J Pediatr Gastroenterol Nutr. 2007;45(3):366–9. Epub 2007/09/18. pmid:17873753.
- 11. Sellers EA, Clark I, Tavakoli M, Dean HJ, McGavock J, Malik RA. The acceptability and feasibility of corneal confocal microscopy to detect early diabetic neuropathy in children: a pilot study. Diabet Med. 2013;30(5):630–1. Epub 2013/01/18. pmid:23323870.
- 12. Nelson D, Mah JK, Adams C, Hui S, Crawford S, Darwish H, et al. Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes. Pediatric diabetes. 2006;7(6):305–10. Epub 2007/01/11. pmid:17212597.
- 13. Xiong Q, Lu B, Ye HY, Liu SY, Zheng HP, Zhang RY, et al. Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy. Diabetes research and clinical practice. 2018;136:85–92. Epub 2017/12/10. pmid:29221815.
- 14. Alam U, Jeziorska M, Petropoulos IN, Asghar O, Fadavi H, Ponirakis G, et al. Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy. PLoS One. 2017;12(7):e0180175. Epub 2017/07/19. pmid:28719619.
- 15. Tavakoli M, Begum P, McLaughlin J, Malik RA. Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy. Muscle & nerve. 2015;52(3):363–70. Epub 2015/01/06. pmid:25556884.
- 16. Jiang MS, Yuan Y, Gu ZX, Zhuang SL. Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis. The British journal of ophthalmology. 2016;100(1):9–14. Epub 2015/02/14. pmid:25677672.
- 17. Khan A, Petropoulos IN, Ponirakis G, Menzies RA, Chidiac O, Pasquier J, et al. Corneal confocal microscopy detects severe small fiber neuropathy in diabetic patients with Charcot neuroarthropathy. Journal of diabetes investigation. 2018;9(5):1167–72. Epub 2018/01/31. pmid:29380548.
- 18. Perkins BA, Lovblom LE, Bril V, Scarr D, Ostrovski I, Orszag A, et al. Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study. Diabetologia. 2018;61(8):1856–61. Epub 2018/06/06. pmid:29869146.
- 19. Papanas N, Ziegler D. Corneal confocal microscopy: Recent progress in the evaluation of diabetic neuropathy. Journal of diabetes investigation. 2015;6(4):381–9. Epub 2015/07/30. pmid:26221515.
- 20. Tavakoli M, Petropoulos IN, Malik RA. Corneal confocal microscopy to assess diabetic neuropathy: an eye on the foot. Journal of diabetes science and technology. 2013;7(5):1179–89. Epub 2013/10/16. pmid:24124944.
- 21. Kamran S, Khan A, Salam A, Akhtar N, Petropoulos I, Ponirakis G, et al. Cornea: A Window to White Matter Changes in Stroke; Corneal Confocal Microscopy a Surrogate Marker for the Presence and Severity of White Matter Hyperintensities in Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020;29(3):104543. Epub 2020/01/07. pmid:31902645.
- 22. Gad H, Khan A, Akhtar N, Kamran S, El-Sotouhy A, Dargham SR, et al. Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke. PLoS One. 2019;14(3):e0213319. Epub 2019/03/16. pmid:30875374.
- 23. Khan A, Kamran S, Akhtar N, Ponirakis G, Al-Muhannadi H, Petropoulos IN, et al. Corneal Confocal Microscopy detects a Reduction in Corneal Endothelial Cells and Nerve Fibres in Patients with Acute Ischemic Stroke. Sci Rep. 2018;8(1):17333. Epub 2018/11/28. pmid:30478334.
- 24. Khan A, Akhtar N, Kamran S, Ponirakis G, Petropoulos IN, Tunio NA, et al. Corneal Confocal Microscopy Detects Corneal Nerve Damage in Patients Admitted With Acute Ischemic Stroke. Stroke. 2017;48(11):3012–8. Epub 2017/10/12. pmid:29018135.
- 25. Ponirakis G, Al Hamad H, Sankaranarayanan A, Khan A, Chandran M, Ramadan M, et al. Association of corneal nerve fiber measures with cognitive function in dementia. Ann Clin Transl Neurol. 2019;6(4):689–97. Epub 2019/04/26. pmid:31019993 and that there are no other persons who satisfied the criteria for authorship and are not listed. We confirm that the order of authors listed in the manuscript has been approved by all authors. None of the authors have received or anticipate receiving income, goods or benefit from a company that will influence the design, conduct, or reporting of the study.
- 26. Petropoulos IN, Kamran S, Li Y, Khan A, Ponirakis G, Akhtar N, et al. Corneal Confocal Microscopy: An Imaging Endpoint for Axonal Degeneration in Multiple Sclerosis. Invest Ophthalmol Vis Sci. 2017;58(9):3677–81. Epub 2017/07/21. pmid:28727882.
- 27. Kass-Iliyya L, Leung M, Marshall A, Trotter P, Kobylecki C, Walker S, et al. The perception of affective touch in Parkinson’s disease and its relation to small fibre neuropathy. Eur J Neurosci. 2017;45(2):232–7. Epub 2016/11/20. pmid:27859794.
- 28. Sankaranarayanan A, Malik RA. Can corneal confocal microscopy help in early detection of neuronal damage and cognitive dysfunction as a consequence of metabolic syndrome in schizophrenia? Early Interv Psychiatry. 2017;11(3):271–4. Epub 2015/07/16. pmid:26177108.
- 29. Szalai E, Deak E, Modis L Jr., Nemeth G, Berta A, Nagy A, et al. Early Corneal Cellular and Nerve Fiber Pathology in Young Patients With Type 1 Diabetes Mellitus Identified Using Corneal Confocal Microscopy. Invest Ophthalmol Vis Sci. 2016;57(3):853–8. Epub 2016/03/05. pmid:26943147.
- 30. Ferdousi M, Romanchuk K, Mah JK, Virtanen H, Millar C, Malik RA, et al. Early corneal nerve fibre damage and increased Langerhans cell density in children with type 1 diabetes mellitus. Sci Rep. 2019;9(1):8758. Epub 2019/06/21. pmid:31217448.
- 31. Deak EA, Szalai E, Toth N, Malik RA, Berta A, Csutak A. Longitudinal Changes in Corneal Cell and Nerve Fiber Morphology in Young Patients with Type 1 Diabetes with and without Diabetic Retinopathy: A 2-Year Follow-up Study. Invest Ophthalmol Vis Sci. 2019;60(2):830–7. Epub 2019/02/28. pmid:30811546.
- 32. Pacaud D, Romanchuk KG, Tavakoli M, Gougeon C, Virtanen H, Ferdousi M, et al. The Reliability and Reproducibility of Corneal Confocal Microscopy in Children. Invest Ophthalmol Vis Sci. 2015;56(9):5636–40. Epub 2015/08/28. pmid:26313299.
- 33. Petropoulos IN, Ferdousi M, Marshall A, Alam U, Ponirakis G, Azmi S, et al. The Inferior Whorl For Detecting Diabetic Peripheral Neuropathy Using Corneal Confocal Microscopy. Invest Ophthalmol Vis Sci. 2015;56(4):2498–504. Epub 2015/03/19. pmid:25783609.
- 34. Malik RA, Kallinikos P, Abbott CA, van Schie CH, Morgan P, Efron N, et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003;46(5):683–8. Epub 2003/05/10. pmid:12739016.
- 35. Tavakoli M, Quattrini C, Abbott C, Kallinikos P, Marshall A, Finnigan J, et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care. 2010;33(8):1792–7. Epub 2010/05/04. pmid:20435796.
- 36. Tuzun E, Gurses C, Baykan B, Buyukbabani N, Ozturk AS, Gokyigit A. Lafora body-like inclusions in a case of progressive myoclonic ataxia associated with coeliac disease. Eur Neurol. 2001;46(3):157–8. Epub 2001/10/13. pmid:11598336.
- 37. Brannagan TH 3rd, Hays AP, Chin SS, Sander HW, Chin RL, Magda P, et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol. 2005;62(10):1574–8. Epub 2005/10/12. pmid:16216941.
- 38. De Sousa EA, Hays AP, Chin RL, Sander HW, Brannagan TH 3rd. Characteristics of patients with sensory neuropathy diagnosed with abnormal small nerve fibres on skin biopsy. Journal of neurology, neurosurgery, and psychiatry. 2006;77(8):983–5. Epub 2006/07/18. pmid:16844956.
- 39. Souayah N, Chin RL, Brannagan TH, Latov N, Green PH, Kokoszka A, et al. Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol. 2008;15(12):1300–3. Epub 2008/12/04. pmid:19049545.
- 40. Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease. Brain. 1966;89(4):683–722. Epub 1966/12/01. pmid:4163580.
- 41. Cooke WT, Johnson AG, Woolf AL. Vital staining and electron microscopy of the intramuscular nerve endings in the neuropathy of adult coeliac disease. Brain. 1966;89(4):663–82. Epub 1966/12/01. pmid:4163579.
- 42. Hadjivassiliou M, Grunewald RA, Kandler RH, Chattopadhyay AK, Jarratt JA, Sanders DS, et al. Neuropathy associated with gluten sensitivity. Journal of neurology, neurosurgery, and psychiatry. 2006;77(11):1262–6. Epub 2006/07/13. pmid:16835287.
- 43. Squintani G, Ferrari S, Caramaschi P, Cavallaro T, Refatti N, Rizzuto N, et al. Multineuropathy in a patient with HBV infection, polyarteritis nodosa and celiac disease. Rheumatol Int. 2009;29(5):579–81. Epub 2008/09/24. pmid:18810449.
- 44. Thawani S, Brannagan TH 3rd, Lebwohl B, Mollazadegan K, Green PHR, Ludvigsson JF. Type 1 Diabetes, Celiac Disease, and Neuropathy-A Nationwide Cohort Study. Journal of clinical neuromuscular disease. 2017;19(1):12–8. Epub 2017/08/23. pmid:28827484.
- 45. Simonati A, Battistella PA, Guariso G, Clementi M, Rizzuto N. Coeliac disease associated with peripheral neuropathy in a child: a case report. Neuropediatrics. 1998;29(3):155–8. Epub 1998/08/26. pmid:9706627.
- 46. Edwards K, Pritchard N, Dehghani C, Vagenas D, Russell A, Malik RA, et al. Corneal confocal microscopy best identifies the development and progression of neuropathy in patients with type 1 diabetes. J Diabetes Complications. 2017;31(8):1325–7. Epub 2017/05/30. pmid:28551295.
- 47. Edwards K, Pritchard N, Vagenas D, Russell A, Malik RA, Efron N. Standardizing corneal nerve fibre length for nerve tortuosity increases its association with measures of diabetic neuropathy. Diabet Med. 2014;31(10):1205–9. Epub 2014/04/23. pmid:24750318.
- 48. Kallinikos P, Berhanu M, O’Donnell C, Boulton AJ, Efron N, Malik RA. Corneal nerve tortuosity in diabetic patients with neuropathy. Invest Ophthalmol Vis Sci. 2004;45(2):418–22. Epub 2004/01/28. pmid:14744880.
- 49. Utsunomiya T, Nagaoka T, Hanada K, Omae T, Yokota H, Abiko A, et al. Imaging of the Corneal Subbasal Whorl-like Nerve Plexus: More Accurate Depiction of the Extent of Corneal Nerve Damage in Patients With Diabetes. Invest Ophthalmol Vis Sci. 2015;56(9):5417–23. Epub 2015/08/19. pmid:26284545.
- 50. Tummanapalli SS, Issar T, Kwai N, Pisarcikova J, Poynten AM, Krishnan AV, et al. A Comparative Study on the Diagnostic Utility of Corneal Confocal Microscopy and Tear Neuromediator Levels in Diabetic Peripheral Neuropathy. Curr Eye Res. 2019:1–10. Epub 2019/12/18. pmid:31842622.
- 51. Yan A, Issar T, Tummanapalli SS, Markoulli M, Kwai NCG, Poynten AM, et al. Relationship between corneal confocal microscopy and markers of peripheral nerve structure and function in Type 2 diabetes. Diabet Med. 2020;37(2):326–34. Epub 2019/03/22. pmid:30897245.
- 52. Kalteniece A, Ferdousi M, Petropoulos I, Azmi S, Adam S, Fadavi H, et al. Greater corneal nerve loss at the inferior whorl is related to the presence of diabetic neuropathy and painful diabetic neuropathy. Sci Rep. 2018;8(1):3283. Epub 2018/02/21. pmid:29459766.
- 53. Kalteniece A, Ferdousi M, Azmi S, Mubita WM, Marshall A, Lauria G, et al. Corneal confocal microscopy detects small nerve fibre damage in patients with painful diabetic neuropathy. Sci Rep. 2020;10(1):3371. Epub 2020/02/27. pmid:32099076.
- 54. Anitua E, Muruzabal F, Tayebba A, Riestra A, Perez VL, Merayo-Lloves J, et al. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol. 2015;93(8):e605–14. Epub 2015/04/03. pmid:25832910.
- 55. Fea AM, Aragno V, Testa V, Machetta F, Parisi S, D’Antico S, et al. The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study. Biomed Res Int. 2016;2016:8406832. Epub 2016/05/21. pmid:27200376.